“… 19 , 20 , 43 , 90 , 99 Although the evidence may be determined as anecdotal, most of the patients who received ECTR (especially hemoperfusion or hemodialysis) appeared to improve rapidly after initiation of the procedure and had an uneventful outcome, including some patients who reportedly ingested doses greater than 500 mg/kg, 29 , 30 , 60 , 62 , 64 , 72 , 85 and who had concentrations over 60 mg/L (254 μmol/L). 8 , 12 , 16 , 51 , 60 , 66 , 70 , 75 , 79 , 82 , 88 , 120 Patients receiving less effective treatments, such as continuous renal replacement therapies (CRRT) and peritoneal dialysis, improved less quickly, over days. 56 , 59 , 85 , 118 Reported complications of ECTRs were almost exclusively associated with hemoperfusion and included hypocalcemia, hypotension, and thrombocytopenia.…”